C2N Diagnostics Releases the PrecivityAD2™ Blood Test for Clinical Care, a Robust Assay with High Co
PrecivityAD2 Aims to Set a New Performance Standard for Blood Biomarkers in Alzheimer’s Disease Diagnosis With Combined Measures of Amyloid Beta (Aβ42/40) and Tau Protein (p-tau217/np-tau217) RatiosPrecivity AD2 is Expected to Serve Major Unmet Need for an Accurate and Accessible Test Given the Availability of New D...
Source: pharmiweb.com